Can a radioactive 'Smart Bomb' shrink resistant prostate tumors?
Disease control
Ongoing
This early-stage trial tests a new drug called PSW-1025, which delivers a radioactive particle (astatine-211) directly to prostate cancer cells. The goal is to see if this targeted approach is safe and tolerable for men with castration-resistant prostate cancer, a form that no lo…
Phase: PHASE1 • Sponsor: Osaka University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC